Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 12 ($0.15) and last traded at GBX 12.68 ($0.16), with a volume of 8805 shares traded. The stock had previously closed at GBX 12.66 ($0.16).
Celadon Pharmaceuticals Stock Down 12.0 %
The business’s 50-day moving average is GBX 25.06 and its two-hundred day moving average is GBX 48.02. The firm has a market capitalization of £7.57 million, a price-to-earnings ratio of -137.50 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a quick ratio of 6.97 and a current ratio of 1.92.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- Tesla Poised to Hit Record Highs This Holiday Season
- Industrial Products Stocks Investing
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is the Nasdaq? Complete Overview with History
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
